All Stories

  1. Exploratory Evaluation of Circulating Microbiota-Derived Corisin Levels in Women with Adverse Pregnancy Outcomes

    Article • Antioxidants, May 2025, MDPI AG

    Esteban Gabazza

  2. The Impact of Comorbidities on Serum IgG Levels and Exacerbation Risk in Chronic Obstructive Pulmonary Disease

    Article • American Review of Respiratory Disease, April 2025, American Thoracic Society

    Esteban Gabazza

  3. Endoscopic Features of Early Autoimmune Gastritis: Insights From a Case Study in a Young Male Patient

    Article • January 2025, MDPI AG

    Esteban Gabazza

  4. Endobronchial tuberculosis mimicking malignancy: Lessons from a case report

    Article • Respiratory Medicine Case Reports, January 2025, Elsevier

    Esteban Gabazza

  5. Transforming Lung Cancer Management: A Promising Case Study of Immune Checkpoint Inhibitor Success Following a Multidisciplinary Approach

    Article • Diagnostics, September 2024, MDPI AG

    Esteban Gabazza

  6. Inhibiting iNKT Cell Activation: A Promising Strategy Against Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, September 2024, American Thoracic Society

    Esteban Gabazza

  7. Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant

    Article • Cells, September 2024, MDPI AG

    Esteban Gabazza

  8. The Protective Role of KANK1 in Podocyte Injury

    Article • International Journal of Molecular Sciences, May 2024, MDPI AG

    Esteban Gabazza

  9. Cell Death in Acute Organ Injury and Fibrosis

    Article • International Journal of Molecular Sciences, April 2024, MDPI AG

    Esteban Gabazza

  10. Hangeshashinto-Associated Mesenteric Phlebosclerosis and Highly Atypical Adenoma Requiring Laparoscopic Right Hemicolectomy

    Article • Diagnostics, March 2024, MDPI AG

    Esteban Gabazza

  11. Leveraging Microbiome Composition Variability for Precision Medicine in Idiopathic Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, January 2024, American Thoracic Society

    Esteban Gabazza

  12. Adenine Nucleotide Translocases and Cellular Senescence in Idiopathic Pulmonary Fibrosis

    Article • American Journal of Respiratory Cell and Molecular Biology, December 2023, American Thoracic Society

    Esteban Gabazza

  13. Epoprostenol and Treprostinil: Differential Effects on Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension

    Article • American Review of Respiratory Disease, September 2023, American Thoracic Society

    Esteban Gabazza

  14. Antimicrobial Effects of Lactoferrin against Helicobacter pylori Infection

    Article • Pathogens, April 2023, MDPI AG

    Esteban Gabazza

  15. Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression

    Article • International Journal of Molecular Sciences, April 2023, MDPI AG

    Esteban Gabazza

  16. Culture Conditions for Mycelial Growth and Anti-Cancer Properties of Termitomyces

    Article • Mycobiology, March 2023, Taylor & Francis

    Esteban Gabazza

  17. Bioactive Compounds from the Mushroom-Forming Fungus Chlorophyllum molybdites

    Article • Antibiotics, March 2023, MDPI AG

    Esteban Gabazza

  18. Axl, Immune Checkpoint Molecules and HIF Inhibitors from the Culture Broth of Lepista luscina

    Article • Molecules, December 2022, MDPI AG

    Esteban Gabazza

  19. Is the uPA/PAI-1 Ratio a Marker of Sonographic Septations in Pleural Infection?

    Article • American Review of Respiratory Disease, November 2022, American Thoracic Society

    Esteban Gabazza

  20. Transforming Growth Factorβ1 Overexpression Is Associated with Insulin Resistance and Rapidly Progressive Kidney Fibrosis under Diabetic Conditions

    Article • International Journal of Molecular Sciences, November 2022, MDPI AG

    Esteban Gabazza

  21. Is Helicobacter pylori infection inversely correlated with atopic, skin, and autoimmune diseases?

    Article • Allergy, September 2022, Wiley

    Esteban Gabazza

  22. Acute Calculous Cholecystitis Caused by Streptococcus gallolyticus subspecies pasteurianus: A Case Report

    Article • Microorganisms, September 2022, MDPI AG

    Esteban Gabazza

  23. Measurement of Intermediate Frequency Magnetic Fields Generated by Household Induction Cookers for Epidemiological Studies and Development of an Exposure Estimation Model

    Article • International Journal of Environmental Research and Public Health, September 2022, MDPI AG

    Esteban Gabazza

  24. Microbial Burden-Associated Cytokine Storm May Explain Non-Resolving ARDS in COVID-19 Patients

    Article • American Review of Respiratory Disease, July 2022, American Thoracic Society

    Esteban Gabazza

  25. Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report

    Article • Pharmaceuticals, July 2022, MDPI AG

    Esteban Gabazza

  26. Is the Efficacy of Adding Ramucirumab to Docetaxel Related to a History of Immune Checkpoint Inhibitors in the Real-World Clinical Practice?

    Article • Cancers, June 2022, MDPI AG

    Esteban Gabazza

  27. The Need for a CYFRA 21-1 Cut-off Value to Predict Clinical Progression of IPF in Clinical Practice

    Article • American Review of Respiratory Disease, May 2022, American Thoracic Society

    Esteban Gabazza

  28. Chronic Fibrosis and Its Progression to Cancer

    Article • International Journal of Molecular Sciences, April 2022, MDPI AG

    Esteban Gabazza

  29. Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis

    Article • Nature Communications, March 2022, Springer Science + Business Media

    Esteban Gabazza

  30. Complete Genome Sequences of Three Staphylococcus haemolyticus Strains Isolated from the Lung of a TGFβ1 Transgenic Mouse with Lung Fibrosis

    Article • Microbiology Resource Announcements, March 2022, ASM Journals

    Esteban Gabazza

  31. Correlation of total serum HDL particles with a predictor of mortality risk in idiopathic pulmonary fibrosis

    Article • European Respiratory Journal, February 2022, European Respiratory Society (ERS)

    Esteban Gabazza

  32. The Fairy Chemical Imidazole-4-carboxamide Inhibits the Expression of Axl, PD-L1, and PD-L2 and Improves Response to Cisplatin in Melanoma

    Article • Cells, January 2022, MDPI AG

    Esteban Gabazza

  33. The Clinical Relevance of Infection and Its Treatment in Microscopic Polyangiitis With or Without Interstitial Lung Disease

    Article • CHEST Journal, December 2021, Elsevier

    Esteban Gabazza

  34. The Potential of Digital Polymerase Chain Reaction for Improving Diagnostic Yield of Nontuberculous Mycobacteria Pulmonary Disease

    Article • Infection and Drug Resistance, December 2021, Taylor & Francis

    Esteban Gabazza

  35. Response of Lung Microbiota to Changes of Pulmonary Innate Immunity Under Healthy Conditions

    Article • American Review of Respiratory Disease, November 2021, American Thoracic Society

    Esteban Gabazza

  36. Case Report: A Difficult-to-Diagnose Case of Hyperinsulinemic Hypoglycemia Surgically Treated After Developing Acute Pancreatitis

    Article • Frontiers in Endocrinology, October 2021, Frontiers

    Esteban Gabazza

  37. A Microbiome-Derived Peptide Induces Apoptosis of Cells from Different Tissues

    Article • Cells, October 2021, MDPI AG

    Esteban Gabazza

  38. Podocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis

    Article • Scientific Reports, October 2021, Springer Science + Business Media

    Esteban Gabazza

  39. Role of activation of the coagulation system in the pathogenesis of urticaria

    Article • Allergy, September 2021, Wiley

    Esteban Gabazza

  40. No Strong Evidence for Ruling Out the Role of Coagulation in Long-Term Disability after Critical Illness

    Article • American Review of Respiratory Disease, September 2021, American Thoracic Society

    Esteban Gabazza

  41. Protective Role of Recombinant Human Thrombomodulin in Diabetes Mellitus

    Article • Cells, August 2021, MDPI AG

    Esteban Gabazza

  42. Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case report

    Article • World Journal of Clinical Cases, August 2021, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Esteban Gabazza

  43. The role of cigarette smoking-derived pollutants in the risk of mortality in idiopathic pulmonary fibrosis

    Article • European Respiratory Journal, August 2021, European Respiratory Society (ERS)

    Esteban Gabazza

  44. Subcritical Water Extracts from Agaricus blazei Murrill’s Mycelium Inhibit the Expression of Immune Checkpoint Molecules and Axl Receptor

    Article • Journal of Fungi, July 2021, MDPI AG

    Esteban Gabazza

  45. Subcritical Water Extracts from Agaricus blazei Murrill's Mycelium Inhibits the Expression of Immune Checkpoint Molecules and Axl receptor

    Article • July 2021, MDPI AG

    Esteban Gabazza

  46. Oral Limonite Supplement Ameliorates Glucose Intolerance in Diabetic and Obese Mice

    Article • Journal of Inflammation Research, July 2021, Taylor & Francis

    Esteban Gabazza

  47. Degradation Products of Complex Arabinoxylans by Bacteroides intestinalis Enhance the Host Immune Response

    Article • Microorganisms, May 2021, MDPI AG

    Esteban Gabazza

  48. Increased expression of Protein S in eyes with diabetic retinopathy and diabetic macular edema

    Article • Scientific Reports, May 2021, Springer Science + Business Media

    Esteban Gabazza

  49. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report

    Article • World Journal of Clinical Cases, May 2021, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Esteban Gabazza

  50. Increased Reflux Esophagitis after Helicobacter pylori Eradication Therapy in Cases Undergoing Endoscopic Submucosal Dissection for Early Gastric Cancer

    Article • Cancers, April 2021, MDPI AG

    Esteban Gabazza

  51. Second‐line therapy with first‐ or second‐generation tyrosine kinase inhibitors in EGFR ‐mutated non‐small cell lung cancer patients with T790M ‐negative or unidentified mutation

    Article • Thoracic Cancer, February 2021, Wiley

    Esteban Gabazza

  52. Degradation of complex arabinoxylans by human colonic Bacteroidetes

    Article • Nature Communications, January 2021, Springer Science + Business Media

    Esteban Gabazza

  53. Sudden Death Associated with Severe Hypoglycemia in a Diabetic Patient During Sensor-Augmented Pump Therapy with the Predictive Low Glucose Management System

    Article • American Journal of Case Reports, January 2021, International Scientific Literature

    Esteban Gabazza

  54. Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorβ1-Driven Lung Fibrosis

    Article • Frontiers in Pharmacology, November 2020, Frontiers

    Esteban Gabazza

  55. Coagulation markers as predictors for clinical events in COPD

    Article • Respirology, November 2020, Wiley

    Esteban Gabazza

  56. Thrombomodulin ameliorates transforming growth factor-β1–mediated chronic kidney disease via the G-protein coupled receptor 15/Akt signal pathway

    Article • Kidney International, November 2020, Elsevier

    Esteban Gabazza

  57. A Prediction Equation to Assess Resting Energy Expenditure in Japanese Patients with COPD

    Article • Journal of Clinical Medicine, October 2020, MDPI AG

    Esteban Gabazza

  58. De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma

    Article • Cancers, October 2020, MDPI AG

    Esteban Gabazza

  59. Axl and immune checkpoints inhibitors from fruiting bodies of Pleurocybella porrigens

    Article • The Journal of Antibiotics, May 2020, Springer Science + Business Media

    Esteban Gabazza

  60. A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis

    Article • Nature Communications, March 2020, Springer Science + Business Media

    Esteban Gabazza

  61. Plant growth regulators and Axl and immune checkpoint inhibitors from the edible mushroom Leucopaxillus giganteus

    Article • Bioscience Biotechnology and Biochemistry, March 2020, Taylor & Francis

    Esteban Gabazza

  62. Too Premature to Deny the Potential of Thrombomodulin-alfa in Idiopathic Pulmonary Fibrosis

    Article • American Review of Respiratory Disease, March 2020, American Thoracic Society

    Esteban Gabazza

  63. Protein S protects against allergic bronchial asthma by modulating Th1/Th2 balance

    Article • Allergy, March 2020, Wiley

    Esteban Gabazza

  64. Factors leading to failure to diagnose pulmonary malignant tumors using endobronchial ultrasound with guide sheath within the target lesion

    Article • September 2019, Springer Science + Business Media

    Esteban Gabazza

  65. Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges

    Article • International Journal of Molecular Sciences, September 2019, MDPI AG

    Esteban Gabazza

  66. Protective Role of Matrix Metalloproteinase-2 in Allergic Bronchial Asthma

    Article • Frontiers in Immunology, August 2019, Frontiers

    Esteban Gabazza

  67. Risk factors for lung cancer in COPD – results from the Bergen COPD cohort study

    Article • Respiratory Medicine, June 2019, Elsevier

    Esteban Gabazza

  68. Protein S is Protective in Acute Lung Injury by Inhibiting Cell Apoptosis

    Article • International Journal of Molecular Sciences, March 2019, MDPI AG

    Esteban Gabazza

  69. Chk1-mediated Cdc25A degradation as a critical mechanism for normal cell cycle progression

    Article • Journal of Cell Science, January 2019, The Company of Biologists

    Esteban Gabazza

  70. Canagliflozin improves obesity and insulin resistance in a diabetic patient with Cushing's disease undergoing postoperative steroid therapy: A case report

    Article • Biomedical Reports, October 2018, Spandidos Publications

    Esteban Gabazza

  71. Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor

    Article • American Review of Respiratory Disease, October 2018, American Thoracic Society

    Esteban Gabazza

  72. Renal Injury during Long-Term Crizotinib Therapy

    Article • International Journal of Molecular Sciences, September 2018, MDPI AG

    Esteban Gabazza

  73. Role of Matrix Metalloproteinase-2 in Eosinophil-Mediated Airway Remodeling

    Article • Frontiers in Immunology, September 2018, Frontiers

    Esteban Gabazza

  74. Comparable immunoreactivity rates of PD-L1 in archival and recent specimens from non-small cell lung cancer

    Article • Thoracic Cancer, September 2018, Wiley

    Esteban Gabazza

  75. Identification of Halophilic Microbes in Lung Fibrotic Tissue by Oligotyping

    Article • Frontiers in Microbiology, August 2018, Frontiers

    Esteban Gabazza

  76. Long Noncoding RNA CAT104 Promotes Cell Viability, Migration, and Invasion in Gastric Carcinoma Cells Through Activation of MicroRNA-381-Inhibiting Zinc Finger E-box-Binding Homeobox 1 (ZEB1) Expression

    Article • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, August 2018, Cognizant Communication Corporation

    Esteban Gabazza

  77. A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer

    Article • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, August 2018, Cognizant Communication Corporation

    Esteban Gabazza

  78. Protein S Exacerbates Chronic Liver Injury and Fibrosis

    Article • American Journal Of Pathology, May 2018, Elsevier

    Esteban Gabazza

  79. Anti-apoptotic activity of human matrix metalloproteinase-2 attenuates diabetes mellitus

    Article • Metabolism, May 2018, Elsevier

    Esteban Gabazza

  80. The Medicinal Mushroom, Grifola gargal, Ameliorates Allergic Bronchial Asthma

    Article • Journal of Medicinal Food, February 2018, Mary Ann Liebert Inc

    Esteban Gabazza

  81. Mice overexpressing latent matrix metalloproteinase-2 develop lung emphysema after short-term exposure to cigarette smoke extract

    Article • Biochemical and Biophysical Research Communications, February 2018, Elsevier

    Esteban Gabazza

  82. Inhibition of Cell Apoptosis and Amelioration of Pulmonary Fibrosis by Thrombomodulin

    Article • American Journal Of Pathology, October 2017, Elsevier

    Esteban Gabazza

  83. Low dose of alcohol attenuates pro-atherosclerotic activity of thrombin

    Article • Atherosclerosis, October 2017, Elsevier

    Esteban Gabazza

  84. Smart watch‑based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease

    Article • Experimental and Therapeutic Medicine, September 2017, Spandidos Publications

    Esteban Gabazza

  85. Recent studies move closer to answering questions about sequential therapy for anaplastic lymphoma kinase-rearranged non-small cell lung cancer

    Article • Journal of Thoracic Disease, September 2017, AME Publishing Company

    Esteban Gabazza

  86. Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis

    Article • Gene Therapy, August 2017, Springer Science + Business Media

    Esteban Gabazza

  87. Adenosine isolated from Grifola gargal promotes glucose uptake via PI3K and AMPK signalling pathways in skeletal muscle cells

    Article • Journal of Functional Foods, June 2017, Elsevier

    Esteban Gabazza

  88. β2 adrenergic agonist suppresses eosinophil-induced epithelial-to-mesenchymal transition of bronchial epithelial cells

    Article • May 2017, Springer Science + Business Media

    Esteban Gabazza

  89. Restrictive IL-10 induction by an innocuous parainfluenza virus vector ameliorates nasal allergy

    Article • Journal of Allergy and Clinical Immunology, February 2017, Elsevier

    Esteban Gabazza

  90. Sequential Therapy with Crizotinib and Alectinib in ALK -Rearranged Non–Small Cell Lung Cancer—A Multicenter Retrospective Study

    Article • Journal of Thoracic Oncology, February 2017, Elsevier

    Esteban Gabazza

  91. Interleukin-33 induces mucin gene expression and goblet cell hyperplasia in human nasal epithelial cells

    Article • Cytokine, February 2017, Elsevier

    Esteban Gabazza

  92. Comparison of Glucose Area Under the Curve Measured Using Minimally Invasive Interstitial Fluid Extraction Technology with Continuous Glucose Monitoring System in Diabetic Patients

    Article • Diabetes & Metabolism Journal, January 2017, Korean Diabetes Association (KAMJE)

    Esteban Gabazza

  93. Sequential Use of ALK Inhibitors: An Optional Approach

    Article • Journal of Thoracic Oncology, December 2016, Elsevier

    Esteban Gabazza

  94. “Pseudoprogression” of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy

    Article • Journal of Thoracic Oncology, October 2016, Elsevier

    Esteban Gabazza

  95. Efficacy of crizotinib in ALK fusion variants

    Article • Journal of Thoracic Disease, October 2016, AME Publishing Company

    Esteban Gabazza

  96. Enhanced wound healing by topical application of ointment containing a low concentration of povidone-iodine

    Article • Journal of Wound Care, September 2016, Mark Allen Group

    Esteban Gabazza

  97. Smart watch for monitoring physical activity in patients with chronic obstructive pulmonary disease

    Article • European Respiratory Journal, September 2016, European Respiratory Society (ERS)

    Esteban Gabazza

  98. Smart watch for monitoring physical activity in patients with chronic obstructive pulmonary disease

    Article • Respiratory Investigation, July 2016, Elsevier

    Esteban Gabazza

  99. Protein S is protective in pulmonary fibrosis

    Article • Journal of Thrombosis and Haemostasis, June 2016, Wiley

    Esteban Gabazza

  100. Amelioration of Diabetes by Protein S

    Article • Diabetes, May 2016, American Diabetes Association

    Esteban Gabazza

  101. Circulating fibrocytes correlate with the asthma control test score

    Article • Allergologia et Immunopathologia, May 2016, Elsevier

    Esteban Gabazza

  102. A Case of Lung Adenocarcinoma-associated Acromegaly That Survived for 3 Years Under Chemotherapy

    Article • Haigan, January 2016, Japan Lung Cancer Society

    Esteban Gabazza

  103. Jejunoiletitis Associated with Adult-onset Familial Mediterranean Fever

    Article • Internal Medicine, January 2016, Japanese Society of Internal Medicine

    Esteban Gabazza

  104. Association of Waist Circumference and Body Fat Weight with Insulin Resistance in Male Subjects with Normal Body Mass Index and Normal Glucose Tolerance

    Article • Internal Medicine, January 2016, Japanese Society of Internal Medicine

    Esteban Gabazza

  105. Lung overexpression of matrix metalloproteinase-2 protects against bronchial asthma

    Article • September 2015, European Respiratory Society (ERS)

    Esteban Gabazza

  106. Amelioration of Atherosclerosis by the New Medicinal Mushroom Grifola gargal Singer

    Article • Journal of Medicinal Food, August 2015, Mary Ann Liebert Inc

    Esteban Gabazza

  107. Improvement in early diagnosis of Japanese spotted fever by using a novel Rick PCR system

    Article • The Journal of Dermatology, July 2015, Wiley

    Esteban Gabazza

  108. Endoscopic findings and lesion distribution in amebic colitis

    Article • Journal of Infection and Chemotherapy, June 2015, Elsevier

    Esteban Gabazza

  109. Activated protein C modulates the proinflammatory activity of dendritic cells

    Article • Journal of Asthma and Allergy, May 2015, Dove Medical Press

    Esteban Gabazza

  110. Olopatadine, a non-sedating H1 antihistamine, decreases the nocturnal scratching without affecting sleep quality in atopic dermatitis

    Article • Experimental Dermatology, February 2015, Wiley

    Esteban Gabazza

  111. Second and Third-look Endoscopy for the Prevention of Post-ESD Bleeding

    Article • Medicine, February 2015, Wolters Kluwer Health

    Esteban Gabazza

  112. Effects of Sugar-Sweetened Beverage Intake on the Development of Type 2 Diabetes Mellitus in Subjects with Impaired Glucose Tolerance: the Mihama Diabetes Prevention Study

    Article • Journal of Nutritional Science and Vitaminology, January 2015, Center for Academic Publications Japan

    Esteban Gabazza

  113. Thrombomodulin inhibits the activation of eosinophils and mast cells

    Article • Cellular Immunology, January 2015, Elsevier

    Esteban Gabazza

  114. Usefulness of Small Intestinal Endoscopy in a Case of Adult-onset Familial Mediterranean Fever Associated with Jejunoileitis

    Article • Internal Medicine, January 2015, Japanese Society of Internal Medicine

    Esteban Gabazza

  115. Synergistic Effect of Bolus Exposure to Zinc Oxide Nanoparticles on Bleomycin-Induced Secretion of Pro-Fibrotic Cytokines without Lasting Fibrotic Changes in Murine Lungs

    Article • International Journal of Molecular Sciences, December 2014, MDPI AG

    Professor Yasuhiko HAYASHI, Esteban Gabazza

  116. Protein S exacerbates alcoholic hepatitis by stimulating liver natural killer T cells

    Article • Journal of Thrombosis and Haemostasis, December 2014, Wiley

    Esteban Gabazza

  117. Is there still hope for single therapies: How do we set up experimental systems to efficiently test combination therapies?

    Article • Respirology, November 2014, Wiley

    Esteban Gabazza

  118. Persistent Release of IL-1s from Skin Is Associated with Systemic Cardio-Vascular Disease, Emaciation and Systemic Amyloidosis: The Potential of Anti-IL-1 Therapy for Systemic Inflammatory Diseases

    Article • PLOS One, August 2014, PLOS

    Esteban Gabazza

  119. Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils

    Article • The Journal of Dermatology, August 2014, Wiley

    Esteban Gabazza

  120. Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils

    Article • Biochemical and Biophysical Research Communications, July 2014, Elsevier

    Esteban Gabazza

  121. Novel acoustic evaluation system for scratching behavior in itching dermatitis: Rapid and accurate analysis for nocturnal scratching of atopic dermatitis patients

    Article • The Journal of Dermatology, February 2014, Wiley

    Esteban Gabazza

  122. Thrombomodulin Modulates Dendritic Cells via Both Antagonism of High Mobility Group Protein B1 and an Independent Mechanism

    Article • Allergology International, January 2014, Japanese Society of Allergology

    Esteban Gabazza

  123. Continuous high-dose antigen exposure preferentially induces IL-10, but intermittent antigen exposure induces IL-4

    Article • Experimental Dermatology, December 2013, Wiley

    Esteban Gabazza

  124. Thrombin-Activatable Fibrinolysis Inhibitor Protects against Acute Lung Injury by Inhibiting the Complement System

    Article • American Journal of Respiratory Cell and Molecular Biology, October 2013, American Thoracic Society

    Esteban Gabazza

  125. A New Strategy for Healthcare-Associated Pneumonia: A 2-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-Resistant Pathogens to Select Initial Empiric Therapy

    Article • Clinical Infectious Diseases, September 2013, Oxford University Press (OUP)

    Esteban Gabazza

  126. Differential Gene Expression in Thrombomodulin (TM; CD141)+ and TM− Dendritic Cell Subsets

    Article • PLOS One, August 2013, PLOS

    Esteban Gabazza

  127. Dose-dependent differential effects of thrombin in allergic bronchial asthma

    Article • Journal of Thrombosis and Haemostasis, August 2013, Wiley

    Esteban Gabazza

  128. Branched-Chain Amino Acid Supplementation Reduces Oxidative Stress and Prolongs Survival in Rats with Advanced Liver Cirrhosis

    Article • PLOS One, July 2013, PLOS

    Esteban Gabazza

  129. CD8+ T cell granzyme B activates keratinocyte endogenous IL-18

    Article • Archives of Dermatological Research, July 2013, Springer Science + Business Media

    Esteban Gabazza

  130. Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses

    Article • Cancer Science, June 2013, Wiley

    Esteban Gabazza

  131. Eosinophils Promote Epithelial to Mesenchymal Transition of Bronchial Epithelial Cells

    Article • PLOS One, May 2013, PLOS

    Esteban Gabazza

  132. Synthesis of 18O-labeled RNA for application to kinetic studies and imaging

    Article • Nucleic Acids Research, April 2013, Oxford University Press (OUP)

    Esteban Gabazza

  133. Thrombin-activatable fibrinolysis inhibitor (TAFI) is enhanced in major trauma patients without infectious complications

    Article • Immunobiology, April 2013, Elsevier

    Esteban Gabazza

  134. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis

    Article • Immunobiology, February 2013, Elsevier

    Esteban Gabazza

  135. Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa) Levels are decreased in Patients With Trauma-Induced Coagulopathy

    Article • Thrombosis Research, January 2013, Elsevier

    Esteban Gabazza

  136. Three-dimensional computed tomography angiography for the preoperative evaluation of coronary artery disease in lung cancer patients

    Article • World Journal of Surgical Oncology, January 2013, Springer Science + Business Media

    Esteban Gabazza, MD, PhD Motoshi Takao

  137. Ustekinumab Improves Psoriasis without Altering T Cell Cytokine Production, Differentiation, and T Cell Receptor Repertoire Diversity

    Article • PLOS One, December 2012, PLOS

    Esteban Gabazza

  138. Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2012, Taylor & Francis

    Esteban Gabazza

  139. Comment on serum FGF21 and RBP4 levels in patients with chronic hepatitis C

    Article • Scandinavian Journal of Gastroenterology, August 2012, Taylor & Francis

    Esteban Gabazza

  140. Efficacy of a Novel Class of RNA Interference Therapeutic Agents

    Article • PLOS One, August 2012, PLOS

    Esteban Gabazza

  141. Correlation of circulating dehydroepiandrosterone with activated protein C generation and carotid intima-media thickness in male patients with Type 2 diabetes

    Article • Diabetic Medicine, June 2012, Wiley

    Esteban Gabazza

  142. Regional reduction in gray and white matter volume in brains of cirrhotic patients: voxel-based analysis of MRI

    Article • Metabolic Brain Disease, May 2012, Springer Science + Business Media

    Esteban Gabazza

  143. Caucasian ethnicity as a risk factor for more severe mucosal damage in gastroesophageal reflux disease

    Article • Esophagus, May 2012, Springer Science + Business Media

    Esteban Gabazza

  144. Regulatory Role Of Thrombin In Allergic Bronchial Asthma

    Article • May 2012, American Thoracic Society

    Esteban Gabazza

  145. Role Of Thrombin-Activatable Fibrinolysis Inhibitor And The Complement System In Acute Lung Injury

    Article • May 2012, American Thoracic Society

    Esteban Gabazza

  146. Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases

    Article • Respirology, April 2012, Wiley

    Esteban Gabazza

  147. Heat-killed bacillus Calmette-Guérin andMycobacterium kansasiiantigen 85B combined vaccination ameliorates dermatitis in a mouse model of atopic dermatitis by inducing regulatory T cells

    Article • British Journal of Dermatology, April 2012, Wiley

    Esteban Gabazza

  148. Exogenous activated protein C inhibits the progression of diabetic nephropathy

    Article • Journal of Thrombosis and Haemostasis, March 2012, Elsevier

    Esteban Gabazza

  149. Development and Preclinical Efficacy of Novel Transforming Growth Factor-β1 Short Interfering RNAs for Pulmonary Fibrosis

    Article • American Journal of Respiratory Cell and Molecular Biology, March 2012, American Thoracic Society

    Esteban Gabazza

  150. Calcineurin Inhibitors Suppress Cytokine Production from Memory T Cells and Differentiation of Naïve T Cells into Cytokine-Producing Mature T Cells

    Article • PLOS One, February 2012, PLOS

    Esteban Gabazza

  151. Evaluation of Basophil CD203c as a Predictor of Carboplatin-Related Hypersensitivity Reaction in Patients with Gynecologic Cancer

    Article • Biological and Pharmaceutical Bulletin, January 2012, Pharmaceutical Society of Japan

    Esteban Gabazza

  152. TNF-α is associated with loss of lean body mass only in already cachectic COPD patients

    Article • Respiratory Research, January 2012, Springer Science + Business Media

    Esteban Gabazza

  153. Intratumoral Injection of Propionibacterium acnes Suppresses Malignant Melanoma by Enhancing Th1 Immune Responses

    Article • PLOS One, December 2011, PLOS

    Esteban Gabazza

  154. Role of Thrombin-Activatable Fibrinolysis Inhibitor in Allergic Bronchial Asthma

    Article • Lung, October 2011, Springer Science + Business Media

    Esteban Gabazza

  155. Solitary pulmonary nodule of benign metastasizing leiomyoma associated with primary lung cancer: a case report

    Article • Journal of Medical Case Reports, October 2011, Springer Science + Business Media

    Esteban Gabazza

  156. Single step modified ink staining for Tzanck test: Quick detection of herpetic giant cells in Tzanck smear

    Article • The Journal of Dermatology, September 2011, Wiley

    Esteban Gabazza

  157. Risk for local recurrence of early gastric cancer treated with piecemeal endoscopic mucosal resection during a 10-year follow-up period

    Article • Surgical Endoscopy, July 2011, Springer Science + Business Media

    Esteban Gabazza

  158. Effect of suppressor of cytokine signaling on hepcidin production in hepatitis C virus replicon cells

    Article • Hepatology Research, February 2011, Wiley

    Esteban Gabazza

  159. Propionibacterium acnes vaccination induces regulatory T cells and Th1 immune responses and improves mouse atopic dermatitis

    Article • Experimental Dermatology, January 2011, Wiley

    Esteban Gabazza

  160. Atherosclerosis Amelioration by Moderate Alcohol Consumption Is Associated With Increased Circulating Levels of Stromal Cell-Derived Factor-1

    Article • Circulation Journal, January 2011, Japanese Circulation Society

    Esteban Gabazza

  161. Role of Thrombin in Chronic Rhinosinusitis–associated Tissue Remodeling

    Article • American Journal of Rhinology and Allergy, January 2011, SAGE Publications

    Esteban Gabazza

  162. SLIT Improves Cedar Pollinosis by Restoring IL-10 Production from Tr1 and Monocytes~IL-10 Productivity Is Critical for Becoming Allergic~

    Article • Allergology International, January 2011, Japanese Society of Allergology

    Esteban Gabazza

  163. Inhibition of Allergic Bronchial Asthma by Thrombomodulin Is Mediated by Dendritic Cells

    Article • American Review of Respiratory Disease, January 2011, American Thoracic Society

    Esteban Gabazza

  164. Phosphoinositide 3-kinase induced activation and cytoskeletal translocation of protein kinase CK2 in protease activated receptor 1-stimulated platelets

    Article • Thrombosis Research, December 2010, Elsevier

    Esteban Gabazza

  165. High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice

    Article • Journal of Thrombosis and Haemostasis, November 2010, Wiley

    Esteban Gabazza

  166. Granzyme B is a novel interleukin-18 converting enzyme

    Article • Journal of Dermatological Science, August 2010, Elsevier

    Esteban Gabazza

  167. Deficiency Of Thrombin-activatable Fibrinolysis Inhibitor Worsens Bronchial Asthma

    Article • May 2010, American Thoracic Society

    Esteban Gabazza

  168. Nine cases of Japan spotted fever diagnosed at our hospital in 2008

    Article • International Journal of Dermatology, April 2010, Wiley

    Esteban Gabazza

  169. Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor

    Article • Journal of Thrombosis and Haemostasis, April 2010, Wiley

    Esteban Gabazza

  170. Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients

    Article • Respiratory Medicine, April 2010, Elsevier

    Esteban Gabazza

  171. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial

    Article • BMJ, March 2010, BMJ

    Esteban Gabazza

  172. 1,24-Dihydroxyvitamin D3 (tacalcitol) prevents skin T-cell infiltration

    Article • British Journal of Dermatology, February 2010, Wiley

    Esteban Gabazza

  173. What has been learnt from the Thrombin Activatable Fibrinolysis Inhibitor (TAFI)-deficient mouse?

    Article • Journal of Thrombosis and Haemostasis, January 2010, Wiley

    Esteban Gabazza

  174. Direct effects of protein S in ameliorating acute lung injury

    Article • Journal of Thrombosis and Haemostasis, December 2009, Wiley

    Esteban Gabazza

  175. Reactive Nitrogen Species Mediate DNA Damage inHelicobacter pylori-Infected Gastric Mucosa

    Article • Helicobacter, December 2009, Wiley

    Esteban Gabazza

  176. Induction of IL-10–producing regulatory T cells with TCR diversity by epitope-specific immunotherapy in pollinosis

    Article • Journal of Allergy and Clinical Immunology, October 2009, Elsevier

    Esteban Gabazza

  177. Increased interferon-γ, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris

    Article • Journal of Dermatological Science, July 2009, Elsevier

    Esteban Gabazza

  178. The Coagulation and Protein C Pathways in Patients with Sleep Apnea

    Article • Lung, June 2009, Springer Science + Business Media

    Esteban Gabazza

  179. A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody

    Article • Diabetes Research and Clinical Practice, June 2009, Elsevier

    Esteban Gabazza

  180. IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis

    Article • British Journal of Dermatology, June 2009, Wiley

    Esteban Gabazza

  181. Connexin32 is expressed in vascular endothelial cells and participates in gap-junction intercellular communication

    Article • Biochemical and Biophysical Research Communications, May 2009, Elsevier

    Esteban Gabazza

  182. Different bile concentration of micafungin and itraconazole in a patient with candidal cholecystitis

    Article • Journal of Infection, April 2009, Elsevier

    Esteban Gabazza

  183. Presence of Thrombin-Activatable Fibrinolysis Inhibitor inHelicobacter pylori-Associated Gastroduodenal Disease

    Article • Helicobacter, April 2009, Wiley

    Esteban Gabazza

  184. Protein S Inhibits the Secretion of Inflammatory Cytokines from Alveolar Epithelial Cells.

    Article • April 2009, American Thoracic Society

    Esteban Gabazza

  185. Procoagulant and Anticoagulant Factors in Patients with Sleep Apnea.

    Article • April 2009, American Thoracic Society

    Esteban Gabazza

  186. Differential Regulatory Function of Resting and Preactivated Allergen-Specific CD4+CD25+ Regulatory T Cells in Th2-Type Airway Inflammation

    Article • The Journal of Immunology, November 2008, The American Association of Immunologists

    Esteban Gabazza

  187. Regulatory mechanisms of C4b-binding protein (C4BP)α and β expression in rat hepatocytes by lipopolysaccharide and interleukin-6

    Article • Journal of Thrombosis and Haemostasis, November 2008, Wiley

    Esteban Gabazza

  188. Role of the coagulation system in allergic inflammation in the upper airways

    Article • Clinical Immunology, November 2008, Elsevier

    Esteban Gabazza

  189. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly

    Article • Respiratory Medicine, September 2008, Elsevier

    Esteban Gabazza

  190. Protein C inhibitor regulates hepatocyte growth factor activator-mediated liver regeneration in mice

    Article • Gut, March 2008, BMJ

    Esteban Gabazza

  191. Role of thrombin in interleukin-5 expression from basophils

    Article • Biochemical and Biophysical Research Communications, March 2008, Elsevier

    Esteban Gabazza

  192. Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency

    Article • Thrombosis and Haemostasis, January 2008, Thieme Publishing Group

    Esteban Gabazza

  193. Inhibition of Nuclear Factor-κB in T Cells Suppresses Lung Fibrosis

    Article • American Review of Respiratory Disease, December 2007, American Thoracic Society

    Esteban Gabazza

  194. Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients

    Article • Diabetic Medicine, December 2007, Wiley

    Esteban Gabazza

  195. Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy-associated tubulointerstitial fibrosis

    Article • Journal of Thrombosis and Haemostasis, November 2007, Wiley

    Esteban Gabazza

  196. Monocyte chemoattractant protein-1 promoter −2518 polymorphism is associated with post-challenge insulin and glucose levels in non-diabetic Japanese subjects

    Article • Diabetes Research and Clinical Practice, November 2007, Elsevier

    Esteban Gabazza

  197. Intracellular localization of protein C inhibitor (PCI) and urinary plasminogen activator in renal tubular epithelial cells from humans and human PCI gene transgenic mice

    Article • Histochemistry and Cell Biology, September 2007, Springer Science + Business Media

    Esteban Gabazza

  198. Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator

    Article • Journal of Thrombosis and Haemostasis, July 2007, Wiley

    Esteban Gabazza

  199. Unidentified virus-like particles are detected in plasmas with elevated ALT levels: are they significant of etiological agent(s) of non-B, non-C hepatitis?

    Article • Medical Molecular Morphology, March 2007, Springer Science + Business Media

    Esteban Gabazza

  200. Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity

    Article • International Journal of Cancer, January 2007, Wiley

    Esteban Gabazza

  201. Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse

    Article • European Journal of Immunology, December 2006, Wiley

    Esteban Gabazza

  202. Differential regulation of protein S expression in hepatocytes and sinusoidal endothelial cells in rats with cirrhosis

    Article • Journal of Thrombosis and Haemostasis, December 2006, Wiley

    Esteban Gabazza

  203. Protective role of protein C inhibitor in monocrotaline-induced pulmonary hypertension

    Article • Journal of Thrombosis and Haemostasis, November 2006, Wiley

    Esteban Gabazza

  204. Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C

    Article • Journal of Gastroenterology, October 2006, Springer Science + Business Media

    Esteban Gabazza

  205. Decreased High-Molecular Weight Adiponectin-to-Total Adiponectin Ratio in Sera Is Associated With Insulin Resistance in Japanese Metabolically Obese, Normal-Weight Men With Normal Glucose Tolerance

    Article • Diabetes Care, September 2006, American Diabetes Association

    Esteban Gabazza

  206. The ultrastructural morphology of native hepatitis B virus

    Article • Medical Molecular Morphology, September 2006, Springer Science + Business Media

    Esteban Gabazza

  207. Immune complex of hepatitis C virus particles detected by immunogold electron microscopy

    Article • Journal of Gastroenterology, September 2006, Springer Science + Business Media

    Esteban Gabazza

  208. Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance

    Article • Diabetes Research and Clinical Practice, September 2006, Elsevier

    Esteban Gabazza

  209. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients

    Article • Diabetes Research and Clinical Practice, August 2006, Elsevier

    Esteban Gabazza

  210. Lipopolysaccharide-induced decreased protein S expression in liver cells is mediated by MEK/ERK signaling and NF?B activation: involvement of membrane-bound CD14 and toll-like receptor-4

    Article • Journal of Thrombosis and Haemostasis, August 2006, Wiley

    Esteban Gabazza

  211. Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis

    Article • American Journal Of Pathology, April 2006, Elsevier

    Esteban Gabazza

  212. Intratracheal gene transfer of tissue factor pathway inhibitor attenuates pulmonary fibrosis

    Article • Biochemical and Biophysical Research Communications, January 2006, Elsevier

    Esteban Gabazza

  213. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice

    Article • The Journal of Pathology, January 2006, Wiley

    Esteban Gabazza

  214. Decreased protein C activation in patients with fulminant hepatic failure

    Article • Scandinavian Journal of Gastroenterology, January 2006, Taylor & Francis

    Esteban Gabazza

  215. Histamine Type 1 Receptor Deficiency Reduces Airway Inflammation in a Murine Asthma Model

    Article • International Archives of Allergy and Immunology, January 2006, Karger Publishers

    Esteban Gabazza

  216. Anti-inflammatory effect of activated protein C in gastric epithelial cells

    Article • Journal of Thrombosis and Haemostasis, December 2005, Wiley

    Esteban Gabazza

  217. Polymorphism of UDP-glucuronosyltransferase 1A7 gene: A possible new risk factor for lung cancer

    Article • European Journal of Cancer, October 2005, Elsevier

    Esteban Gabazza

  218. Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects

    Article • European Journal of Endocrinology, September 2005, Bioscientifica

    Esteban Gabazza

  219. Vacuolating Cytotoxin A is Associated with Increased Thrombin Generation in Gastric Mucosa

    Article • Helicobacter, August 2005, Wiley

    Esteban Gabazza

  220. Prognostic Impact of Aortic Calcification Index and Ankle-Arm Blood Pressure Indexin Patients under Hemodialysis

    Article • Clinical and Applied Thrombosis/Hemostasis, April 2005, SAGE Publications

    Esteban Gabazza

  221. Radiological and Pathological Correlation of Lung Malignant Tumors Treated with Percutaneous Radiofrequency Ablation

    Article • Internal Medicine, January 2005, Japanese Society of Internal Medicine

    Esteban Gabazza

  222. Quantitative Insulin Sensitivity Check Index Is a Useful Indicator of Insulin Resistance in Japanese Metabolically Obese, Normal-Weight Subjects with Normal Glucose Tolerance

    Article • Endocrine Journal, January 2005, Japan Endocrine Society

    Esteban Gabazza

  223. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus

    Article • European Journal of Endocrinology, November 2004, Bioscientifica

    Esteban Gabazza

  224. Decreased expression of aquaporin-5 in bleomycin-induced lung fibrosis in the mouse

    Article • Pathology International, October 2004, Wiley

    Esteban Gabazza

  225. A Case of Juvenile Myelomonocytic Leukemia With Concomitant Cytomegalovirus Infection

    Article • Journal of Pediatric Hematology/Oncology, September 2004, Wolters Kluwer Health

    Esteban Gabazza

  226. Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditions

    Article • Journal of Thrombosis and Haemostasis, June 2004, Wiley

    Esteban Gabazza

  227. Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice

    Article • Blood, March 2004, American Society of Hematology

    Esteban Gabazza

  228. Tumor Necrosis Factor-  Is Associated With Increased Protein C Activation in Nonobese Type 2 Diabetic Patients

    Article • Diabetes Care, February 2004, American Diabetes Association

    Esteban Gabazza

  229. Progress in the Understanding of Protease-Activated Receptors

    Article • International Journal of Hematology, February 2004, Springer Science + Business Media

    Esteban Gabazza

  230. Increased Oxidative Stress Is Associated With Serum Levels of Triglyceride, Insulin Resistance, and Hyperinsulinemia in Japanese Metabolically Obese, Normal-Weight Men

    Article • Diabetes Care, January 2004, American Diabetes Association

    Esteban Gabazza

  231. Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patients

    Article • American Journal of Hematology, January 2004, Wiley

    Esteban Gabazza

  232. Reflux esophagitis after eradication of Helicobacter pylori is associated with the degree of hiatal hernia

    Article • Scandinavian Journal of Gastroenterology, January 2004, Taylor & Francis

    Esteban Gabazza

  233. Oxidative Stress Is Associated with Adiposity and Insulin Resistance in Men

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2003, Endocrine Society

    Esteban Gabazza

  234. Plasma Levels of Adiponectin Are Associated With Insulin Resistance and Serum Levels of Triglyceride in Japanese Metabolically Obese, Normal-Weight Men With Normal Glucose Tolerance

    Article • Diabetes Care, September 2003, American Diabetes Association

    Esteban Gabazza

  235. In VivoandIn VitroEffects of Macrolide Antibiotics on Mucus Secretion in Airway Epithelial Cells

    Article • American Review of Respiratory Disease, September 2003, American Thoracic Society

    Esteban Gabazza

  236. Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells

    Article • Blood, September 2003, American Society of Hematology

    Esteban Gabazza

  237. Vacuolar H+-ATPase Inhibitor Induces Apoptosis via Lysosomal Dysfunction in the Human Gastric Cancer Cell Line MKN-1

    Article • The Journal of Biochemistry, September 2003, Oxford University Press (OUP)

    Esteban Gabazza

  238. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for overt DIC

    Article • American Journal of Hematology, August 2003, Wiley

    Esteban Gabazza

  239. Lactoferrin sequestration and its contribution to iron-deficiency anemia in Helicobacter pylori-infected gastric mucosa

    Article • Journal of Gastroenterology and Hepatology, August 2003, Wiley

    Esteban Gabazza

  240. Increased Visceral Fat and Serum Levels of Triglyceride Are Associated With Insulin Resistance in Japanese Metabolically Obese, Normal Weight Subjects With Normal Glucose Tolerance

    Article • Diabetes Care, July 2003, American Diabetes Association

    Esteban Gabazza

  241. Association Between Endothelial Nitric Oxide Synthase Glu298Asp Polymorphism and Postchallenge Insulin Levels in Nondiabetic Japanese Subjects

    Article • Diabetes Care, July 2003, American Diabetes Association

    Esteban Gabazza

  242. Increased Soluble Fibrin in Plasma of Patients with Disseminated Intravascular Coagulation

    Article • Clinical and Applied Thrombosis/Hemostasis, July 2003, SAGE Publications

    Esteban Gabazza

  243. Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes

    Article • European Journal of Endocrinology, July 2003, Bioscientifica

    Esteban Gabazza

  244. Effects of Lipid Abnormalities on Arteriosclerosis and Hemostatic Markers in Patients under Hemodialysis

    Article • Clinical and Applied Thrombosis/Hemostasis, July 2003, SAGE Publications

    Esteban Gabazza

  245. Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis

    Article • European Journal of Gastroenterology & Hepatology, July 2003, Wolters Kluwer Health

    Esteban Gabazza

  246. Thrombin-activatable Fibrinolysis Inhibitor and Protein C Inhibitor in Interstitial Lung Disease

    Article • American Review of Respiratory Disease, June 2003, American Thoracic Society

    Esteban Gabazza

  247. Activated Protein C Inhibits the Expression of Platelet-derived Growth Factor in the Lung

    Article • American Review of Respiratory Disease, May 2003, American Thoracic Society

    Esteban Gabazza

  248. Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes

    Article • Diabetes Care, May 2003, American Diabetes Association

    Esteban Gabazza

  249. Increased Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels in Normotensive Type 2 Diabetic Patients with Microalbuminuria

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2003, Endocrine Society

    Esteban Gabazza

  250. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma

    Article • International Journal of Cancer, January 2003, Wiley

    Esteban Gabazza

  251. Atherosclerotic and Hemostatic Abnormalities in Patients Undergoing Hemodialysis

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2003, SAGE Publications

    Esteban Gabazza

  252. Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats – a possible mechanism of intrasinusoidal microthrombus formation and liver dysfunction

    Article • Journal of Hepatology, January 2003, Elsevier

    Esteban Gabazza

  253. Good or Poor Responses of Hemostatic Molecular Markers in Patients with Hematopoietic Disorders After Treatment of Disseminated Intravascular Coagulation

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2003, SAGE Publications

    Esteban Gabazza

  254. Expression and Cytoprotective Effect of Protease-activated Receptor-1 in Gastric Epithelial Cells

    Article • Scandinavian Journal of Gastroenterology, January 2003, Taylor & Francis

    Esteban Gabazza

  255. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients

    Article • American Journal of Hematology, December 2002, Wiley

    Esteban Gabazza

  256. Neither Homeostasis Model Assessment nor Quantitative Insulin Sensitivity Check Index Can Predict Insulin Resistance in Elderly Patients with Poorly Controlled Type 2 Diabetes Mellitus

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2002, Endocrine Society

    Esteban Gabazza

  257. Evaluation of tissue factor antigen level in human seminal plasma

    Article • Urological Research, October 2002, Springer Science + Business Media

    Esteban Gabazza

  258. Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus

    Article • European Journal of Endocrinology, July 2002, Bioscientifica

    Esteban Gabazza

  259. Plasma Levels of Heparin Cofactor II (HCII) and Thrombin-HCII Complex in Patients with Disseminated Intravascular Coagulation

    Article • Clinical and Applied Thrombosis/Hemostasis, July 2002, SAGE Publications

    Esteban Gabazza

  260. Association Between Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels and Activated Protein C in Normotensive Type 2 Diabetic Patients

    Article • Diabetes Care, July 2002, American Diabetes Association

    Esteban Gabazza

  261. QUICKI Is Useful for Following Improvements in Insulin Sensitivity after Therapy in Patients with Type 2 Diabetes Mellitus

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Esteban Gabazza

  262. Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus

    Article • Diabetes Research and Clinical Practice, June 2002, Elsevier

    Esteban Gabazza

  263. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity

    Article • Transfusion, May 2002, Wiley

    Esteban Gabazza

  264. Relationship of the tumor necrosis factor-α −308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus

    Article • Diabetes Research and Clinical Practice, May 2002, Elsevier

    Esteban Gabazza

  265. Molecular aspects of organic compound transport across the plasma membrane of hepatocytes

    Article • Journal of Gastroenterology and Hepatology, April 2002, Wiley

    Esteban Gabazza

  266. Hemostatic Abnormalities Following Bone Marrow Transplantation

    Article • Clinical and Applied Thrombosis/Hemostasis, April 2002, SAGE Publications

    Esteban Gabazza

  267. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer

    Article • American Journal of Hematology, March 2002, Wiley

    Esteban Gabazza

  268. BLEOMYCIN-INDUCED LUNG FIBROSIS: THE AUTHORS SHOULD HAVE USED ANOTHER METHOD TO INDUCE PULMONARY LESIONS RESEMBLING HUMAN IDIOPATHIC PULMONARY FIBROSIS

    Article • American Review of Respiratory Disease, March 2002, American Thoracic Society

    Esteban Gabazza

  269. Conjugated bilirubin decreases the biliary excretion of phospholipids

    Article • Journal of Gastroenterology and Hepatology, February 2002, Wiley

    Esteban Gabazza

  270. Insulin Resistance Is Associated with Increased Circulating Level of Thrombin-Activatable Fibrinolysis Inhibitor in Type 2 Diabetic Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2002, Endocrine Society

    Esteban Gabazza

  271. Activation of Protein C Pathway in the Airways

    Article • Lung, February 2002, Springer Science + Business Media

    Esteban Gabazza

  272. Adenosine inhibits thrombin-induced expression of tissue factor on endothelial cells by a nitric oxide-mediated mechanism

    Article • Clinical Science, February 2002, Portland Press Ltd.

    Esteban Gabazza

  273. Treatment of Malignancy by Activation of the Plasminogen System

    Article • Seminars in Thrombosis and Hemostasis, January 2002, Thieme Publishing Group

    Esteban Gabazza

  274. Activity and Antigen Levels of Thrombin-Activatable Fibrinolysis Inhibitor in Plasma of Patients With Disseminated Intravascular Coagulation

    Article • Thrombosis Research, October 2001, Elsevier

    Esteban Gabazza

  275. Plasma Levels of Total Plasminogen Activator Inhibitor-I (PAI-I) and tPA/PAI-1 Complex in Patients With Disseminated Intravascular Coagulation and Thrombotic Thrombocytopenic Purpura

    Article • Clinical and Applied Thrombosis/Hemostasis, July 2001, SAGE Publications

    Esteban Gabazza

  276. Intratracheal Administration of Activated Protein C Inhibits Bleomycin-induced Lung Fibrosis in the Mouse

    Article • American Review of Respiratory Disease, June 2001, American Thoracic Society

    Esteban Gabazza

  277. Long-term Inhalation of High-dose Nitric Oxide Increases Intraalveolar Activation of Coagulation System in Mice

    Article • American Review of Respiratory Disease, June 2001, American Thoracic Society

    Esteban Gabazza

  278. Role of UGT1A1 mutation in fasting hyperbilirubinemia

    Article • Journal of Gastroenterology and Hepatology, June 2001, Wiley

    Esteban Gabazza

  279. Plasma Levels of Agouti-Related Protein Are Increased in Obese Men

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2001, Endocrine Society

    Esteban Gabazza

  280. Homeostasis Model Assessment Is a Reliable Indicator of Insulin Resistance During Follow-up of Patients With Type 2 Diabetes

    Article • Diabetes Care, February 2001, American Diabetes Association

    Esteban Gabazza

  281. Increased Plasma Thrombomodulin as a Vascular Endothelial Cell Marker in Patients With Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2001, SAGE Publications

    Esteban Gabazza

  282. Plasma levels of natriuretic peptides are correlated with renin activity in normotensive type 2 diabetic patients

    Article • Diabetes Care, December 2000, American Diabetes Association

    Esteban Gabazza

  283. Changes of Hemostatic Molecular Markers After Gynecological Surgery

    Article • Clinical and Applied Thrombosis/Hemostasis, October 2000, SAGE Publications

    Esteban Gabazza

  284. Decreased Protein C Activation Is Associated With Abnormal Collagen Turnover in the Intraalveolar Space of Patients With Interstitial Lung Disease

    Article • Clinical and Applied Thrombosis/Hemostasis, October 2000, SAGE Publications

    Esteban Gabazza

  285. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance

    Article • Journal of Gastroenterology, September 2000, Springer Science + Business Media

    Esteban Gabazza

  286. Role of Activated Protein C in Helicobacter pylori-Associated Gastritis

    Article • Infection and Immunity, May 2000, ASM Journals

    Esteban Gabazza

  287. Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes

    Article • Diabetes Obesity and Metabolism, May 2000, Wiley

    Esteban Gabazza

  288. Hemostatic Abnormalities in Patients With Thrombotic Complications on Maintenance Hemodialysis

    Article • Clinical and Applied Thrombosis/Hemostasis, April 2000, SAGE Publications

    Esteban Gabazza

  289. CT scores of emphysema and oxygen desaturation during low-grade exercise in patients with emphysema

    Article • Acta Radiologica, March 2000, SAGE Publications

    Esteban Gabazza

  290. Role of nitric oxide in airway remodelling

    Article • Clinical Science, March 2000, Portland Press Ltd.

    Esteban Gabazza

  291. Ineffective interferon treatment of chronic hepatitis C-associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels

    Article • Journal of Gastroenterology, January 2000, Springer Science + Business Media

    Esteban Gabazza

  292. Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations

    Article • American Journal of Hematology, January 2000, Wiley

    Professor Maureane Hoffman, Esteban Gabazza

  293. A Case of Obesity, Diabetes and Hypertension Treated with Very Low Calorie Diet (VLCD) followed by Successful Pregnancy with Intrauterine Insemination (IUI).

    Article • Endocrine Journal, January 2000, Japan Endocrine Society

    Esteban Gabazza

  294. Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia

    Article • American Journal of Hematology, January 2000, Wiley

    Esteban Gabazza

  295. State-of-the-Art Review : Elevated Tissue Factor Levels in Leukemic Cell Homogenate

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2000, SAGE Publications

    Esteban Gabazza

  296. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation

    Article • American Journal of Hematology, January 2000, Wiley

    Esteban Gabazza

  297. Etiology of fasting hyperbilirubinemia: Genetic factors versus enhanced enterohepatic cycling of bilirubin

    Article • Gastroenterology, November 1999, Elsevier

    Esteban Gabazza

  298. Prothrombin promotes the invasiveness of melanoma cells by a different mechanism from thrombin

    Article • Fibrinolysis and Proteolysis, November 1999, Elsevier

    Esteban Gabazza

  299. Reply

    Article • Gastroenterology, November 1999, Elsevier

    Esteban Gabazza

  300. Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombo-test monitoring

    Article • Blood Coagulation & Fibrinolysis, October 1999, Wolters Kluwer Health

    Esteban Gabazza

  301. Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease

    Article • American Journal of Hematology, August 1999, Wiley

    Esteban Gabazza

  302. Plasma Brain Natriuretic Peptide Levels in Normotensive Noninsulin-Dependent Diabetic Patients with Microalbuminuria

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1999, Endocrine Society

    Esteban Gabazza

  303. Thrombin in the Airways of Asthmatic Patients

    Article • Lung, July 1999, Springer Science + Business Media

    Esteban Gabazza

  304. Mutation of UGT1A1 Gene in a Case of Crigler-Najjar Syndrome Type II

    Article • The American Journal of Gastroenterology, June 1999, Wolters Kluwer Health

    Esteban Gabazza

  305. Type I collagen metabolites as tumor markers in patients with lung carcinoma

    Article • Cancer, May 1999, Wiley

    Esteban Gabazza

  306. Genetic basis of fasting hyperbilirubinemia

    Article • Gastroenterology, May 1999, Elsevier

    Esteban Gabazza

  307. Hemostatic molecular markers before the onset of disseminated intravascular coagulation

    Article • American Journal of Hematology, April 1999, Wiley

    Esteban Gabazza

  308. Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

    Article • American Journal of Hematology, February 1999, Wiley

    Esteban Gabazza

  309. Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population

    Article • Diabetic Medicine, February 1999, Wiley

    Esteban Gabazza

  310. Aberrations of the Tissue Factor Pathway in Patients Positive for Lupus Anticoagulant

    Article • Clinical and Applied Thrombosis/Hemostasis, January 1999, SAGE Publications

    Esteban Gabazza

  311. Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver disease

    Article • Journal of Clinical Laboratory Analysis, January 1999, Wiley

    Esteban Gabazza

  312. Polyethylene glycol-modified bilirubin oxidase improves hepatic energy charge and urinary prostaglandin levels in rats with obstructive jaundice

    Article • Journal of Hepatology, September 1998, Elsevier

    Esteban Gabazza

  313. Adenosine Regulates Tissue Factor Expression on Endothelial Cells

    Article • Thrombosis Research, July 1998, Elsevier

    Esteban Gabazza

  314. CASE REPORT: Alanine aminotransferase deficiency detected in a patient with chronic hepatitis C

    Article • Journal of Gastroenterology and Hepatology, May 1998, Wiley

    Esteban Gabazza

  315. Circulating Levels of 7 S Domain of Type IV Collagen and Atrial Natriuretic Peptide in Normotensive Type 2 Diabetic Patients with or without Retinopathy

    Article • Hormone and Metabolic Research, February 1998, Thieme Publishing Group

    Esteban Gabazza

  316. Usefulness of Walking Test for Arterial Oxygen Desaturation Screening in General Population

    Article • CHEST Journal, December 1997, Elsevier

    Esteban Gabazza

  317. Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise

    Article • European Respiratory Journal, September 1997, European Respiratory Society (ERS)

    Esteban Gabazza

  318. The effect of low-dose inhalation of nitric oxide in patients with pulmonary fibrosis

    Article • European Respiratory Journal, September 1997, European Respiratory Society (ERS)

    Esteban Gabazza

  319. Serum 7S domain of type IV collagen levels in essential hypertension and hypertensive type 2 diabetic patients

    Article • Diabetic Medicine, June 1997, Wiley

    Esteban Gabazza

  320. Prognostic significance of plasma D-dimer levels in patients with lung cancer

    Article • Thorax, June 1997, BMJ

    Esteban Gabazza

  321. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.

    Article • Journal of Clinical Investigation, May 1997, American Society for Clinical Investigation

    Esteban Gabazza

  322. Acquired Activated Protein C Resistance in Patients with Lupus Anticoagulant and Essential Thrombocythemia

    Article • Clinical and Applied Thrombosis/Hemostasis, April 1997, SAGE Publications

    Esteban Gabazza

  323. Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease.

    Article • American Review of Respiratory Disease, February 1997, American Thoracic Society

    Esteban Gabazza

  324. Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex

    Article • Biochemical Journal, February 1997, Portland Press Ltd.

    Esteban Gabazza

  325. Circulating Intercellular Adhesion Molecule-1 in Patients with Lung Cancer.

    Article • Internal Medicine, January 1997, Japanese Society of Internal Medicine

    Esteban Gabazza

  326. Gastric Juice Levels of Lactoferrin andHelicobacter pyloriInfection

    Article • Scandinavian Journal of Gastroenterology, January 1997, Taylor & Francis

    Esteban Gabazza

  327. Helicobacter pylori Inhibits the Secretory Activity of Gastric Parietal Cells in Patients with Chronic Gastritis: An Ultrastructural Study

    Article • Scandinavian Journal of Gastroenterology, January 1997, Taylor & Francis

    Esteban Gabazza

  328. Detection of helicobacter pylori in biopsy of patients with gastric carcinoma

    Article • Biomedicine & Pharmacotherapy, January 1997, Elsevier

    Esteban Gabazza

  329. Protein C activation in NIDDM patients

    Article • Diabetologia, November 1996, Springer Science + Business Media

    Esteban Gabazza

  330. High plasma level of plasmin-α2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer

    Article • Clinica Chimica Acta, January 1996, Elsevier

    Esteban Gabazza

  331. Characterization of the Binding of Factor Xa to Fibrinogen/Fibrin Derivatives and Localization of the Factor Xa Binding Site on Fibrinogen

    Article • European Journal of Biochemistry, August 1995, Wiley

    Esteban Gabazza

  332. Neutrophil activation and collagen metabolism in lung cancer

    Article • Clinica Chimica Acta, April 1995, Elsevier

    Esteban Gabazza

  333. Alteration of coagulation and fibrinolysis systems after multidrug anticancer therapy for lung cancer

    Article • European Journal of Cancer, January 1994, Elsevier

    Esteban Gabazza

  334. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer

    Article • Cancer, October 1993, Wiley

    Esteban Gabazza

  335. Clinical Characteristics of Pulmonary Tuberculosis in the Compromised Host

    Article • Kansenshogaku zasshi, January 1993, The Japanese Association for Infectious Diseases

    Esteban Gabazza

  336. Evaluating Prethrombotic State In Lung Cancer Using Molecular Markers

    Article • CHEST Journal, January 1993, Elsevier

    Esteban Gabazza

  337. Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer

    Article • Cancer, December 1992, Wiley

    Esteban Gabazza

  338. Bronchopulmonary Disease in Ulcerative Colitis.

    Article • Internal Medicine, January 1992, Japanese Society of Internal Medicine

    Esteban Gabazza

  339. Suspected Multiple Primary Carcinoma ia a Case of Squamous Cell Carcinoma of the Lung with Metastasis to the Stomach.

    Article • Haigan, January 1991, Japan Lung Cancer Society

    Esteban Gabazza